Serum Institute eyes COVID-19 vaccine by Oct.
#GS3 #Pandemic #Science
Pune-based company has partnered with Oxford University in the battle against novel coronavirus
- The city-based Serum Institute of India expects the vaccine for COVID-19 developed by the University of Oxford in the market by October or November provided the safety and efficacy of the product is established during trials.
- The institute has partnered with the Oxford vaccine project as one of the seven global institutions that will manufacture the vaccine.
- Will be able to produce five million doses a month and scale that up to 10 million after six months while typically producing a vaccine takes a long time.
- If the vaccine works in the U.K. trial and we do another trial in India, which we are hoping to start shortly, in safety and efficacy, only then will it be available by October or November and that is only if we start producing at our personal cost in risk by the end of this month.
- However, it will take over two years to set up new manufacturing facility for COVID-19 vaccine. Typically vaccines take many years but with the regulatory approvals in India that have been very carefully changed for this product development.
- SII is currently looking at 4-5 million doses monthly and would start manufacturing early to save time in the hope that the trial would be successful.
- SII would be partnering with ICMR for the clinical trials and that he was in touch with the Department of Biotechnology. The manufacturing plant in Pune would have an investment of ₹500-600 crore.